*YOU MAY INCUR A TINGLING SENSATION
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007
We can't dictate what they do, but they have other options for what their manufacturing, 'cause they've done the studies, they have to determine that that interaction between B6 or carnitine or B12 doesn't interfere with the the GLP-1 drug
Why it matters: Unlike CRP which reflects whole-body inflammation, calprotectin is gut-specific
Fat loss in your face can change the shape of your features and make your eyes and cheeks appear sunken
The findings from previous trials were presented at the American Diabetes Associations 2023 conference and published in a leading medical journal